MODERNA INC (NASDAQ: MRNA)

Overview
current price
$39.39
$39.39
change
-0.17 | -0.43%
-0.17 | -0.43%
Yesterday's Close
39.56
open
39.20
volume
35.48 M
30d. avg volume.
9.59 M
1 day
39.12 - 40.83
52 weeks
35.80 - 170.47
p/e
0.00
beta
1.5824
market cap
15.16 B
dividend yield
0.00%
Industry
-
News and Commentary
Bird Flu Found In Raw Milk Leads To Recall In California Bird flu has been detected in a batch of raw milk sold in California and a voluntary recall of the milk has been issued at the request of the state's department of public health....
Moderna Remains Confident Despite Political Concerns Over Vaccine Safety and HHS Nomination Last week, some large European and U.S. vaccine maker stocks fell in reaction to Robert F. Kennedy Jr.'s nomination to lead the Department of Health and Human Services.
Market Update: Stocks Slip Lower as Postelection Rally Falters Stocks declined on Friday as the postelection rally waned, leading all three major averages to post weekly losses. The Dow Jones Industrial Average sunk over 300 points, while th...
Moderna's Q3 Earnings Beat Overshadowed By Vaccine Demand Slowdown And Market Share Concerns, Analys... On Thursday, Moderna Inc. (MR...
Market Update: S&P 500, Nasdaq Reach New Record Following Fed Interest Rate Cuts The S&P 500 Index and Nasdaq Composite rose to another record high on Thursday as the broader market continued its rally following Donald Trump's election victory and reacted to...
Goldman Sachs Highlights 20 Top Short-Squeeze Opportunities For Q3 Earnings Season Goldman Sachs identified 20 stocks with high short interest that could be primed for a short squeeze, particularly if upcoming earnings reports exceed expectations, providing opp...
Moderna Hit With Another Lawsuit Related To Key COVID-19 Vaccine Technology Northwestern University has filed a patent infringement lawsuit against Moderna, Inc.
The Covid Era Tech Promises To Reinvent Cancer Treatment Pfizer Inc (PFE 
Moderna Outlines Post-Covid Roadmap, Cuts Research Budget, Forecasts 2025 Sales Below Expectations Thursday, Moderna Inc (MRNA
Market Update: Dow Climbs 200 Points on Another In-Line Inflation Report Stocks rose Thursday as investors continued to buy the dip in tech stocks ahead of the Federal Reserve's policy meeting next week. The Dow Jones Industrial Average rose over 200...
StockTwits
StockTwits

Join now and unlock premium features